ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko05340	Primary immunodeficiency	4/27	30/7206	4.0088010072e-06
ko04660	T cell receptor signaling pathway	6/27	124/7206	5.06356124609e-06
ko04658	Th1 and Th2 cell differentiation	5/27	96/7206	2.41886907193e-05
ko04650	Natural killer cell mediated cytotoxicity	5/27	97/7206	2.54381063491e-05
ko04659	Th17 cell differentiation	5/27	106/7206	3.90901976481e-05
ko04062	Chemokine signaling pathway	5/27	201/7206	0.000786120226692
ko03050	Proteasome	3/27	54/7206	0.00102461219797
ko04060	Cytokine-cytokine receptor interaction	4/27	191/7206	0.00520549709186
ko04064	NF-kappa B signaling pathway	3/27	96/7206	0.00531584939688
ko04666	Fc gamma R-mediated phagocytosis	3/27	122/7206	0.0102971425009
ko04380	Osteoclast differentiation	3/27	134/7206	0.013273596676
ko05321	Inflammatory bowel disease (IBD)	2/27	56/7206	0.0183858754329
ko05166	HTLV-I infection	4/27	292/7206	0.0222080969422
ko04640	Hematopoietic cell lineage	2/27	64/7206	0.0236317696625
ko04612	Antigen processing and presentation	2/27	77/7206	0.0332947878341
ko04664	Fc epsilon RI signaling pathway	2/27	77/7206	0.0332947878341
ko04144	Endocytosis	4/27	342/7206	0.0368963072534
ko04662	B cell receptor signaling pathway	2/27	88/7206	0.0424798015659